Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Income
$246.8M
Filings
7,560
Unique Clients
280
Active Period
2010–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
FRONTIER Act
2026 · third_quarter · Client: THE PREDISTRIBUTION INITIATIVE (PDI)
Artificial Intelligence. H.R.9925 - FRONTIER Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R.9925
Digital Asset Market Clarity Act
2026 · third_quarter · Client: WISDOMTREE DIGITAL MANAGEMENT
Issues related to digital assets. SEC regulatory and exemptive relief re: Tokenization.. OCC and Treasury rulemaking to implement GENIUS Act. H.R.3633/S.__ - Digital Asset Market Clarity Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3633
Digital Asset Market Clarity Act
2026 · third_quarter · Client: WISDOMTREE DIGITAL MANAGEMENT
Issues related to digital assets. SEC regulatory and exemptive relief re: Tokenization.. OCC and Treasury rulemaking to implement GENIUS Act. H.R.3633/S.__ - Digital Asset Market Clarity Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3633
Digital Asset Market Clarity Act
2026 · third_quarter · Client: WISDOMTREE DIGITAL MANAGEMENT
Issues related to digital assets. SEC regulatory and exemptive relief re: Tokenization.. OCC and Treasury rulemaking to implement GENIUS Act. H.R.3633/S.__ - Digital Asset Market Clarity Act of 2025.
Client expense: — · Firm income: $30,000
Matched citations: H.R.3633
Hotel Fees Transparency Act of 2025
2026 · third_quarter · Client: TRIPADVISOR LLC
Issues related to treatment of metasearch sites and consumers in the travel industry. H.R.1479/S.314 - The No Hidden Fees on Extra Expenses for Stays Act / S. 2498 Hotel Fees Transparency Act. General issues related to competition in the travel and technology industry.
Client expense: — · Firm income: $50,000
Matched citations: H.R.1479
General issues related to travel and technology. Issues related to Children's Online Safety. H.R.6484 - Kids Online Safety Act. S.281 - TICKET Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R.6484
Hotel Fees Transparency Act of 2024
2026 · third_quarter · Client: TRIPADVISOR LLC
Issues related to treatment of metasearch sites and consumers in the travel industry. H.R.1479/S.314 - The No Hidden Fees on Extra Expenses for Stays Act / S. 2498 Hotel Fees Transparency Act. General issues related to competition in the travel and technology industry.
Client expense: — · Firm income: $50,000
Matched citations: S. 2498
General issues related to travel and technology. Issues related to Children's Online Safety. H.R.6484 - Kids Online Safety Act. S.281 - TICKET Act.
Client expense: — · Firm income: $50,000
Matched citations: S.281
Hotel Fees Transparency Act of 2025
2026 · third_quarter · Client: TRIPADVISOR LLC
Issues related to treatment of metasearch sites and consumers in the travel industry. H.R.1479/S.314 - The No Hidden Fees on Extra Expenses for Stays Act / S. 2498 Hotel Fees Transparency Act. General issues related to competition in the travel and technology industry.
Client expense: — · Firm income: $50,000
Matched citations: S.314
FRONTIER Act
2026 · second_quarter · Client: THE PREDISTRIBUTION INITIATIVE (PDI)
Artificial Intelligence. H.R.9925 - FRONTIER Act.
Client expense: — · Firm income: $10,000
Matched citations: H.R.9925
Biosimilar Red Tape Elimination Act
2026 · third_quarter · Client: THE BIOSIMILARS FORUM
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: H.R.5526
Expedited Access to Biosimilars Act
2026 · third_quarter · Client: THE BIOSIMILARS FORUM
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: H.R.9661
Expedited Access to Biosimilars Act
2026 · third_quarter · Client: THE BIOSIMILARS FORUM
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: H.R.9661
Expedited Access to Biosimilars Act
2026 · third_quarter · Client: THE BIOSIMILARS FORUM
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: S.1414
Expedited Access to Biosimilars Act
2026 · third_quarter · Client: THE BIOSIMILARS FORUM
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: S.1414
Biosimilar Red Tape Elimination Act
2026 · third_quarter · Client: THE BIOSIMILARS FORUM
Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. Inflation Reduction Act implementation. H.R.5526/S.1954 - Biosimilar Red Tape Elimination Act. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: S.1954
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
2026 · third_quarter · Client: THE BIOSIMILARS FORUM
Drug pricing legislation. Labor, Health and Human Services issues. Efforts surrounding user fees. S.2256 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026. H.R.9661/S.1414 - Expedited Access to Biosimilars Act.
Client expense: — · Firm income: $100,000
Matched citations: S.2256
Issues relating to the Child Care and Development Block Grant, Head Start, and Preschool Development Grant Birth through Five. S.846/H.R.1826 - Child Care Workforce Act. Legislation focused on waste, fraud, and abuse in federal child care programs. S.2828/H.R.9224 - Child Care Modernization Act of 2026.
Client expense: — · Firm income: $70,000
Matched citations: H.R.1826
Child Care Modernization Act of 2026
2026 · third_quarter · Client: START EARLY
Issues relating to the Child Care and Development Block Grant, Head Start, and Preschool Development Grant Birth through Five. S.846/H.R.1826 - Child Care Workforce Act. Legislation focused on waste, fraud, and abuse in federal child care programs. S.2828/H.R.9224 - Child Care Modernization Act of 2026.
Client expense: — · Firm income: $70,000
Matched citations: H.R.9224
Issues relating to the Child Care and Development Block Grant, Head Start, and Preschool Development Grant Birth through Five. S.846/H.R.1826 - Child Care Workforce Act. Legislation focused on waste, fraud, and abuse in federal child care programs. S.2828/H.R.9224 - Child Care Modernization Act of 2026.
Client expense: — · Firm income: $70,000
Matched citations: S.2828
Issues relating to the Child Care and Development Block Grant, Head Start, and Preschool Development Grant Birth through Five. S.846/H.R.1826 - Child Care Workforce Act. Legislation focused on waste, fraud, and abuse in federal child care programs. S.2828/H.R.9224 - Child Care Modernization Act of 2026.
Client expense: — · Firm income: $70,000
Matched citations: S.846
Access to Small Business Investor Capital Act
2026 · third_quarter · Client: SMALL BUSINESS INVESTOR ALLIANCE (SBIA)
Preservation and expansion of tax credits to promote investment in American small businesses while encouraging capital formation and investment. Efforts to expand access to long-term patient capital while opposing tax increases on small businesses. H.R.2225 - Access to Small Business Investor Capital Act. H.R.754 - Investing in Main Street Act of 2025.
Client expense: — · Firm income: $20,000
Matched citations: H.R.2225
Access to Small Business Investor Capital Act
2026 · third_quarter · Client: SMALL BUSINESS INVESTOR ALLIANCE (SBIA)
Preservation and expansion of tax credits to promote investment in American small businesses while encouraging capital formation and investment. Efforts to expand access to long-term patient capital while opposing tax increases on small businesses. H.R.2225 - Access to Small Business Investor Capital Act. H.R.754 - Investing in Main Street Act of 2025.
Client expense: — · Firm income: $20,000
Matched citations: H.R.2225
Access to Small Business Investor Capital Act
2026 · third_quarter · Client: SMALL BUSINESS INVESTOR ALLIANCE (SBIA)
Preservation and expansion of tax credits to promote investment in American small businesses while encouraging capital formation and investment. Efforts to expand access to long-term patient capital while opposing tax increases on small businesses. H.R.2225 - Access to Small Business Investor Capital Act. H.R.754 - Investing in Main Street Act of 2025.
Client expense: — · Firm income: $20,000
Matched citations: H.R.2225
Investing in Main Street Act of 2025
2026 · third_quarter · Client: SMALL BUSINESS INVESTOR ALLIANCE (SBIA)
Preservation and expansion of tax credits to promote investment in American small businesses while encouraging capital formation and investment. Efforts to expand access to long-term patient capital while opposing tax increases on small businesses. H.R.2225 - Access to Small Business Investor Capital Act. H.R.754 - Investing in Main Street Act of 2025.
Client expense: — · Firm income: $20,000
Matched citations: H.R.754
Source: Senate LDA